CEDAZURIDINE\DECITABINE for Chronic myelomonocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 135 adverse event reports in the FDA FAERS database where CEDAZURIDINE\DECITABINE was used for Chronic myelomonocytic leukaemia.
Most Reported Side Effects for CEDAZURIDINE\DECITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Transfusion | 229 | 17.8% | 52 | 105 |
| Fatigue | 228 | 17.7% | 43 | 98 |
| Platelet count decreased | 212 | 16.5% | 41 | 104 |
| Death | 205 | 15.9% | 205 | 87 |
| Full blood count abnormal | 188 | 14.6% | 30 | 97 |
| White blood cell count decreased | 175 | 13.6% | 28 | 92 |
| Inappropriate schedule of product administration | 174 | 13.5% | 17 | 87 |
| Product use issue | 150 | 11.7% | 33 | 69 |
| Therapy interrupted | 150 | 11.7% | 24 | 62 |
| Haemoglobin decreased | 132 | 10.3% | 26 | 74 |
| Product use in unapproved indication | 114 | 8.9% | 18 | 57 |
| Asthenia | 105 | 8.2% | 22 | 63 |
| Nausea | 105 | 8.2% | 20 | 48 |
| Pneumonia | 90 | 7.0% | 23 | 74 |
| General physical health deterioration | 87 | 6.8% | 20 | 35 |
Other Indications for CEDAZURIDINE\DECITABINE
Myelodysplastic syndrome (770)
Product used for unknown indication (162)
Acute myeloid leukaemia (103)
Refractory anaemia with an excess of blasts (11)
Myelodysplastic syndrome with excess blasts (10)
Thrombocytopenia (8)
Chronic myeloid leukaemia (7)
Illness (7)
Myelodysplastic syndrome with multilineage dysplasia (7)
Myeloproliferative neoplasm (6)
Other Drugs Used for Chronic myelomonocytic leukaemia
AZACITIDINE (411)
VENETOCLAX (283)
RUXOLITINIB (179)
LENALIDOMIDE (106)
DASATINIB (69)
DECITABINE (67)
HYDROXYUREA (66)
CYCLOPHOSPHAMIDE (51)
FLUDARABINE (42)
CYTARABINE (40)